Abstract

Summary

This paper discusses the potential of targeting sleep and the circadian system as a novel treatment strategy for Parkinson's disease, focusing on the role of the melanopsin containing intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) and the circadian network in the disease.
Categories

Categories

Dementia: The paper discusses the potential role of the circadian processes in neurodegenerative diseases like Parkinson's and Alzheimer's.
Sleep and insomnia: The paper explores the wide range of sleepā€“wake disturbances that occur frequently in Parkinson's disease and the potential of targeting sleep and the circadian system as a treatment strategy.
Cognitive function and memory: The paper discusses the impact of sleep and circadian disruptions on both motor and non-motor symptoms in Parkinson's disease, which could include cognitive function and memory.
Aging: The paper discusses Parkinson's disease, a neurodegenerative disorder that primarily affects older adults.
Phototherapy: The paper discusses the potential of using light therapy as a non-pharmacological strategy to reduce sleep disturbances in Parkinson's disease.
Hormone regulation: The paper discusses the role of melatonin, a hormone that regulates sleep and wakefulness, in the circadian disruptions observed in Parkinson's disease.
Authors

Author(s)

B Feigl, SJG Lewis, O Rawashdeh
Publication Date

Publication Year

2023
Related

Related Publications

View more publications